From June 24th to 26th, Sichuan Zidali Biotechnology Co., Ltd., as a leading manufacturer and technological innovator of plant estrogen products, made its debut at the 23rd World Pharmaceutical Raw Materials China Exhibition and the 18th World Pharmaceutical Machinery, Packaging Equipment and Materials China Exhibition held at the Shanghai New International Expo Center in 2025. This grand event attracted more than 15000 overseas visitors from 166 countries and regions around the world to register, providing a broad platform for communication and cooperation in the pharmaceutical industry.
As a high-tech enterprise dedicated to the research and development, production, and sales of plant estrogen products, Zidali Biotechnology is committed to becoming the largest plant estrogen product manufacturer and technology innovation center in China. At this exhibition, the company showcased its comprehensive business system and won the attention of many attendees for its mature industrial chain from production to trade. The company's flagship products - soybean extract, Sophora japonica extract, Polygonum multiflorum extract, grapefruit extract, Sculcap extract, Polygonum cuspidatum extract, Houttuynia cordata extract, Fructus Aurantii extract and other plant extracts - have become the focus of the natural extract exhibition area with their excellent quality and leading extraction technology. These products not only occupy an important position in the domestic market, but are also exported overseas, providing high-quality raw material support for the global health industry.
In addition, Zidali Biotechnology actively expanded its new product development matrix and showcased new products such as red clover and flaxseed extract for the first time at the exhibition. The company's R&D team stated that these new products are developed based on in-depth research on market trends and precise grasp of consumer health needs, which will further enrich the company's product system and meet the diverse needs of different customers.
During the exhibition, the booth of Zidali Biotechnology attracted a large number of domestic and foreign professional visitors to stop and exchange ideas. The company has reached preliminary cooperation intentions with potential customers from multiple countries and regions such as India, South Korea, and Pakistan, further promoting the internationalization process of the company's products. At the same time, the company has also had in-depth exchanges with many well-known pharmaceutical companies and research institutions in China, laying a solid foundation for future industry university research cooperation.
The person in charge of Sichuan Zidali Biotechnology Co., Ltd. stated that this exhibition is an important opportunity for the company to showcase its strength, expand its market, and strengthen communication. By participating in this international event, the company not only showcased the leading level of Chinese plant estrogen products to the world, but also injected new impetus into its own development. In the future, the company will continue to increase research and development investment, constantly innovate, improve product quality and service level, and contribute more to the development of the global health industry.
With the continuous promotion of the World Pharmaceutical Raw Materials China Exhibition and the World Pharmaceutical Machinery, Packaging Equipment and Materials China Exhibition, Sichuan Zidali Biotechnology Co., Ltd. is expected to achieve more results on this international stage, helping China's pharmaceutical industry occupy a more important position in the global industrial chain.
Standardized Plant Extract,Plant Extract,Soybean Extract,Standardized Extract.
